GEA Group AG

Latest Results (01.08.2026):

GEA Group AG — Q1 2026: GEA started 2026 with broadly improved results: order intake rose to EUR 1,454.2m (reported +2.8%, organic +6.4%), revenue to EUR 1,273.1m (reported +1.2%, organic +5.3%), and profitability measures strengthened (EBITDA before restructuring EUR 205.9m; EBITDA margin before restructuring 16.2%). Profit for the period was EUR 99.7m and EPS EUR 0.61. Cash generation weakened in the quarter with free cash flow of EUR ‑190.3m, and net liquidity stood at EUR 162.4m. The group confirmed its 2026 outlook. (All figures per GEA Group AG Q1 2026 report.)

Orders and backlog — GEA Group AG Q1 2026

Order intake: EUR 1,454.2m (Q1 2026), book‑to‑bill 1.14 (vs 1.12 in Q1 2025). Order backlog increased to EUR 3,500.6m (+8.1%). Growth was broad‑based organically (+6.4), driven by base (

Revenue and service mix — GEA Group AG Q1 2026

Revenue: EUR 1,273.1m (Q1 2026; reported +1.2%, organic +5.3%). Service revenue remained high at EUR 524.9m, representing 41.2% of group revenue (slight decline vs Q1 2025). Book‑to‑bill improvement and organic machine and service growth supported the top line.

Profitability — GEA Group AG Q1 2026

EBITDA before restructuring expenses: EUR 205.9m (+3.9% y/y) with a margin of 16.2% (up 42 bps). EBIT before restructuring: EUR 152.3m; reported EBIT EUR 147.0m. Profit for the period: EUR 99.7m (+5.7%). EPS: EUR 0.61; EPS before restructuring: EUR 0.64.

Cash flow and liquidity — GEA Group AG Q1 2026

Operating cash flow: EUR ‑124.7m; investing cash flow: EUR ‑65.6m; free cash flow: EUR ‑190.3m (Q1 2026). Net liquidity at 31 March 2026: EUR 162.4m (decline vs year‑end 2025 driven by NWC build‑up and negative FCF).

Working capital, balance sheet and ROCE — GEA Group AG Q1 2026

Net working capital (reporting date): EUR 383.4m, equal to 7.0% of last‑12‑month revenue (at lower end of 7–9% target range). Total assets ~EUR 6.10bn; equity ratio 42.6%. ROCE improved to 35.7% (Q1 2026).

Divisional snapshot — GEA Group AG Q1 2026

Pure Flow Processing: strong order growth (+8.6% to EUR 550.5m), revenue EUR 474.6m, EBITDA margin ~26.5%. Nutrition Plant Engineering: order intake down (‑4.5) and revenue declined (‑7.8%), EBITDA margin weakened to 8.0%. Pharma & Food Applications: modest revenue, EBITDA margin improved to 13.4%. Farm Technologies: robust growth (revenue +21.3%), EBITDA margin increased to 16.7%.

Outlook — GEA Group AG Q1 2026

GEA confirmed its 2026 guidance: organic sales growth +5.0% to +7.0%, EBITDA margin before restructuring 16.6%–17.2%, and ROCE 34.0%–38.0%. Management cites geopolitical risks (Middle East) but keeps the forecast unchanged.